NCT05776095View on ClinicalTrials.gov

Evaluation of Safety and Performance Outcomes of Eyedeal IOL Implantation After Cataract Removal

NARecruitingINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Lens Implantation, Intraocular
Interventions
PROCEDURE

Cataract surgery

Subjects will undergo surgery to remove cataract (the cloudy lenses) via phacoemulsification, and implant the Eyedeal® Model PX65AS1 IOL in the eye capsule.

DEVICE

Eyedeal® Model PX65AS1 IOL

Subjects will undergo surgery to remove cataract (the cloudy lenses) via phacoemulsification, and implant the Eyedeal® Model PX65AS1 IOL in the eye capsule.

Trial Locations (2)

50161

RECRUITING

Department of Ophthalmology, Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas

69120

NOT_YET_RECRUITING

University Eye Clinic Heidelberg, Heidelberg

All Listed Sponsors
lead

Xi'an Eyedeal Medical Technology Co., Ltd

INDUSTRY